Literature DB >> 15111100

Crystal structure of human monoamine oxidase B, a drug target enzyme monotopically inserted into the mitochondrial outer membrane.

Claudia Binda1, Frantisek Hubálek, Min Li, Dale E Edmondson, Andrea Mattevi.   

Abstract

Monoamine oxidase B (MAO B) is an outer mitochondrial membrane protein that oxidizes arylalkylamine neurotransmitters and has been a valuable drug target for many neurological disorders. The 1.7 angstrom resolution structure of human MAO B shows the enzyme is dimeric with a C-terminal transmembrane helix protruding from each monomer and anchoring the protein to the membrane. This helix departs perpendicularly from the base of the structure in a different way with respect to other monotopic membrane proteins. Several apolar loops exposed on the protein surface are located in proximity of the C-terminal helix, providing additional membrane-binding interactions. One of these loops (residues 99-112) also functions in opening and closing the MAO B active site cavity, which suggests that the membrane may have a role in controlling substrate binding.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15111100     DOI: 10.1016/S0014-5793(04)00209-1

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  A Protein Structure Initiative approach to expression, purification, and in situ delivery of human cytochrome b5 to membrane vesicles.

Authors:  Pablo Sobrado; Michael A Goren; Declan James; Carissa K Amundson; Brian G Fox
Journal:  Protein Expr Purif       Date:  2007-12-15       Impact factor: 1.650

Review 2.  Predicting monoamine oxidase inhibitory activity through ligand-based models.

Authors:  Santiago Vilar; Giulio Ferino; Elias Quezada; Lourdes Santana; Carol Friedman
Journal:  Curr Top Med Chem       Date:  2012       Impact factor: 3.295

3.  Insights into the binding mode of new N-substituted pyrazoline derivatives to MAO-A: docking and quantum chemical calculations.

Authors:  Safiye Sağ Erdem; Seyhan Türkkan; Kemal Yelekçi; Nesrin Gökhan-Kelekçi
Journal:  J Neural Transm (Vienna)       Date:  2012-12-16       Impact factor: 3.575

4.  Topological probes of monoamine oxidases A and B in rat liver mitochondria: inhibition by TEMPO-substituted pargyline analogues and inactivation by proteolysis.

Authors:  Jin Wang; Dale E Edmondson
Journal:  Biochemistry       Date:  2011-03-07       Impact factor: 3.162

5.  Docking of novel reversible monoamine oxidase-B inhibitors: efficient prediction of ligand binding sites and estimation of inhibitors thermodynamic properties.

Authors:  K Yelekçi; O Karahan; M Toprakçi
Journal:  J Neural Transm (Vienna)       Date:  2007-03-31       Impact factor: 3.575

6.  Monoamine oxidase inhibitory activities of novel 3,4-dihydroquinolin-(1H)-2-one derivatives.

Authors:  S G Sunal; S Yabanoglu; A Yesilada; G Ucar
Journal:  J Neural Transm (Vienna)       Date:  2007-03-26       Impact factor: 3.575

Review 7.  Selective MAO-B inhibitors: a lesson from natural products.

Authors:  Simone Carradori; Melissa D'Ascenzio; Paola Chimenti; Daniela Secci; Adriana Bolasco
Journal:  Mol Divers       Date:  2013-11-12       Impact factor: 2.943

8.  ADP competes with FAD binding in putrescine oxidase.

Authors:  Erik W van Hellemond; Hortense Mazon; Albert J Heck; Robert H H van den Heuvel; Dominic P H M Heuts; Dick B Janssen; Marco W Fraaije
Journal:  J Biol Chem       Date:  2008-08-04       Impact factor: 5.157

9.  Expression of zebrafish (Danio rerio) monoamine oxidase (MAO) in Pichia pastoris: purification and comparison with human MAO A and MAO B.

Authors:  Betül Kacar Arslan; Dale E Edmondson
Journal:  Protein Expr Purif       Date:  2010-01-14       Impact factor: 1.650

10.  First experimental evidence of dopamine interactions with negatively charged model biomembranes.

Authors:  Katarzyna Jodko-Piorecka; Grzegorz Litwinienko
Journal:  ACS Chem Neurosci       Date:  2013-05-10       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.